⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23598636 | 1.00 | — | — | |
| SCHEMBL10614207 | 1.00 | — | — | |
| SCHEMBL13504570 | 0.96 | — | — | |
| Hydrochloric Acid SCHEMBL518222 | 0.96 | — | — | |
| Hydrochloric Acid SCHEMBL2306666 | 0.96 | — | — | |
| SCHEMBL716246 | 0.95 | — | — | |
| Hydrochloric Acid SCHEMBL1442403 | 0.91 | — | — | |
| SCHEMBL221682 | 0.80 | — | — | |
| SCHEMBL18245095 | 0.75 | CA1 (0.35) | — | |
| SCHEMBL11057613 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 608 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250353862-A1 | C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER | ANIMA BIOTECH INC. (US) | 2025-11-20 | — | — | US | claimed |
| EP-4547671-A1 | C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER | Anima Biotech Inc. (US) | 2025-05-07 | — | — | EP | claimed |
| CN-118620151-A | Fluorine-containing piperidine type anion exchange membrane and preparation method thereof | 大连理工大学 | 2024-09-10 | — | — | CN | claimed |
| US-20240246940-A1 | HETEROARYL DERIVATIVE COMPOUND AND USE THEREOF | VORONOI INC. (KR) | 2024-07-25 | — | — | US | claimed |
| WO-2024151346-A1 | HETEROARYL FLUOROALKENES AS DGK INHIBITORS | INCYTE CORPORATION (US) | 2024-07-18 | — | — | WO | claimed |
| CN-115621548-B | Preparation method and application of novel piperidine ionic liquid electrolyte | 深圳大学 | 2024-04-30 | — | — | CN | claimed |
| WO-2024010761-A1 | C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER | ANIMA BIOTECH INC. (US) | 2024-01-11 | — | — | WO | claimed |
| US-20230146944-A1 | HETEROCYCLIC COMPOUNDS AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES | SIGNAL PHARMACEUTICALS, LLC | 2023-05-11 | — | — | US | claimed |
| CN-115621548-A | Preparation method and application of novel piperidine ionic liquid electrolyte | 深圳大学 | 2023-01-17 | — | — | CN | claimed |
| CN-115515567-A | Sound-sensitive liposome and preparation method thereof | 艾姆戈特株式会社 | 2022-12-23 | — | — | CN | claimed |
| EP-1960391-A1 | PIPERAZINE DERIVATIVES AND THEIR USE IN THERAPY | Vernalis (R&D) Limited (GB) | 2008-08-27 | — | — | EP | claimed |
| WO-2008095944-A1 | 7-AZAINDOLE DERIVATIVES AND THEIR USE IN THE INHIBITION OF C-JUN N-TERMINAL KINASE | EISAI R&D MANAGEMENT CO. LTD. (JP) | 2008-08-14 | — | — | WO | claimed |
| WO-2008022013-A1 | KINASE INHIBITORS | ALLERGAN, INC. (US) | 2008-02-21 | — | — | WO | claimed |
| CN-101006097-A | VLA-4 antagonists | MERCK & CO INC (US) | 2007-07-25 | — | — | CN | claimed |
| WO-2007057687-A1 | PIPERAZINE DERIVATIVES AND THEIR USE IN THERAPY | VERNALIS (R & D) LIMITED (GB) | 2007-05-24 | — | — | WO | claimed |
| EP-1165464-B1 | PREPARATION OF SELECTIVELY FLUORINATED ORGANIC COMPOUNDS | F2 CHEMICALS LTD (GB) | 2003-08-20 | — | — | EP | claimed |
| JP-2002540177-A | — | — | 2002-11-26 | — | — | JP | claimed |
| EP-1165464-A1 | PREPARATION OF SELECTIVELY FLUORINATED ORGANIC COMPOUNDS | F2 Chemicals Limited (GB) | 2002-01-02 | — | — | EP | claimed |
| WO-2000058241-A1 | PREPARATION OF SELECTIVELY FLUORINATED ORGANIC COMPOUNDS | F2 CHEMICALS LIMITED (GB) | 2000-10-05 | — | — | WO | claimed |
| EP-0775132-A1 | (AZETIDIN-1-YLALKYL)LACTAMS AS TACHYKININ ANTAGONISTS | Pfizer Limited (GB) | 1997-05-28 | — | — | EP | claimed |